PAREXEL International

26 Abonné

Headquartered near Boston, Massachusetts, PAREXEL has offices in 85 locations in 52 countries around the world, and has approximately 18,900 employees. We provide the most comprehensive drug development capabilities of any CRO worldwide. Our global regulatory expertise, Phase I-IV clinical research services, integrated eClinical technologies, and advanced commercialization services all work together to move you through the development journey more smoothly and cost-effectively from beginning to end.

clinical trials research clinical research organization clinical trials pharmaceutical pharma business consulting contract research organization healthcare cro parexel regulatory prxl biopharmaceutical biopharmaceuticals clinical research data clincal trials drug development market access research clinical trial supply chain biosimilars medical devices medical china supply chain market analysis technology wearables oncology partnerships biotechnology asia tech europe japan real world evidence global market size big data information technology azure allergan microsoft cloud computing cloud business services sensors measurement health outcomes smartphone technology techonology adaptation earlyphaseoncology dia0217 personalized medicine genomics precision medicine imaging endpoint irt siteuserexperience strategic partnership imaging endpoints

Tout plus

Activité
À propos

Utilization of Clinical Pharmacology Data to Support a Demonstration of Biosimilarity

il y a 8 ans • 428 Vues

Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporate Vice President, Medical Imaging

il y a 8 ans • 1042 Vues

Realizing Late Phase Value Through Strategic Partnerships with CROs by Joshua SchultzCorporate Vice President, PAREXEL Peri and Post Approval Services

il y a 8 ans • 1189 Vues

PAREXEL International

Présentations

Utilization of Clinical Pharmacology Data to Support a Demonstration of Biosimilarity

Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporate Vice President, Medical Imaging

Realizing Late Phase Value Through Strategic Partnerships with CROs by Joshua SchultzCorporate Vice President, PAREXEL Peri and Post Approval Services

Partnerships in the Clinical Trial Supply Chain by Tom Heely

Applying the Internet of Things to the Clinical Trial Supply Chain

Best Practices to Improve the IRT Site User Experience

Navigating Regulatory Complexities of Biosimilar Development

Effective Late Stage Pathways for Biosimilar Products

Imaging Endpoint Selection for Biosimilar Development

Developing Drugs in the New Era of Personalized Medicines

Early Phase Oncology Trials: A Study in Adaptation

So, My FitBit is Clinical Trial Grade Right?

The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions

Getting to Approval Faster Through Technology Innovation

Why Strategy Is Not Enough

Data Management Roles, Process and Technologies In Risk Based Study Execution

Latin America´s Role In Clinical Studies

You're Hot Then You're Cold - Temperature Management & RTSM Integration

Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD Solutions

Regulatory Strategy In Emerging Markets

Generating Evidence to Drive Patient Access

The Art and Science of Productive FDA Meetings

RIM & IDMP Synergies

Understanding Different Stakeholder Requirements Throughout Commercialization

Development Considerations Comparing Major Markets Including US, EU, Japan and China

Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpoints

Exploring Ways to Enhance Evidence Generation & Communication Planning

FDA Initiatives Under The 21st Century Cures Act

Seamless Dataflow with a Clinical Metadata Repository

Effective Regulatory Strategies for China Market Entry